Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CA3 | P07451 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11409435 | 0.97 | MEN1 (0.41) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| SCHEMBL3079040 | 0.90 | CYP1A2 (0.48) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| SCHEMBL16322423 | 0.89 | MEN1 (0.38) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| SCHEMBL15295706 | 0.87 | PAOX (0.39) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL11403921 | 0.87 | MEN1 (0.46) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| SCHEMBL20362859 | 0.84 | — | — | |
| SCHEMBL5497332 | 0.82 | MEN1 (0.50) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| SCHEMBL12568688 | 0.82 | MEN1 (0.37) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| SCHEMBL12568685 | 0.82 | MEN1 (0.37) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR | |
| Iminoctadiene SCHEMBL15757560 | 0.80 | CYP1A2 (0.59) | MEN1KMT2ACYP1A2SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1753457-A2 | CATIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO., Ltd. (IL) | 2007-02-21 | — | — | EP | claimed |
| WO-2005120573-A2 | CATIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2005-12-22 | — | — | WO | claimed |
| CN-114642735-A | Methods, compositions and systems for delivering therapeutic and diagnostic agents into cells | 菲泽尔克斯公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20210330792-A1 | (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-10-28 | — | — | US | disclosed |
| EP-3461811-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | 3M Innovative Properties Co. (US) | 2019-04-03 | — | — | EP | disclosed |
| US-10239828-B2 | Process for preparing guanidino-functional monomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-03-26 | — | — | US | disclosed |
| EP-3010883-B1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2019-02-20 | — | — | EP | disclosed |
| US-20170183299-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-06-29 | — | — | US | disclosed |
| US-9670149-B2 | Process for preparing guanidino-functional monomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| EP-1753457-B1 | CATIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND USES THEREOF | YEDA RES & DEV (IL) | 2016-08-10 | — | — | EP | disclosed |
| US-9339037-B2 | Synergistic fungicidal active combinations | BAYER CROPSCIENCE AG (DE) | 2016-05-17 | — | — | US | disclosed |
| EP-1251827-B1 | NASALLY ADMINISTRABLE ANTIFUNGAL CYCLIC PEPTIDE COMPOSITIONS | BASILEA PHARMACEUTICA AG (CH) | 2004-05-26 | — | — | EP | disclosed |
| US-6489440-B1 | Cyclic compounds | BASILEA PHARMACEUTICA AG (CH) | 2002-12-03 | — | — | US | disclosed |
| EP-1251827-A2 | NASALLY ADMINISTRABLE CYCLIC PEPTIDE COMPOSITIONS | Basilea Pharmaceutica AG (CH) | 2002-10-30 | — | — | EP | disclosed |
| US-20010038824-A1 | Intranasal cyclic peptide formulations | BASILEA PHARMACEUTICA AG (CH) | 2001-11-08 | — | — | US | disclosed |
| WO-2001052894-A2 | NASALLY ADMINISTRABLE CYCLIC PEPTIDE COMPOSITIONS | BASILEA PHARMACEUTICA AG (CH) | 2001-07-26 | — | — | WO | disclosed |
| EP-1100816-A1 | AEROTHRICIN ANALOGS, THEIR PREPARATION AND USE | F. HOFFMANN-LA ROCHE AG (CH) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000005251-A1 | AEROTHRICIN ANALOGS, THEIR PREPARATION AND USE | F. HOFFMANN-LA ROCHE AG (CH) | 2000-02-03 | — | — | WO | disclosed |
| US-4226852-A | ALKALINITY, AMMONIA-FREE, GUANIDINE DERIVATIVE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1980-10-07 | — | — | US | disclosed |
| US-4186186-A | Guanidine accelerators for peroxide hair bleaching compositions | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1980-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210330792-A1 | (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS | PPOX, PPIB, PPIA | MEN1 3718/4885KMT2A 4216/4885CYP1A2 4476/4885 |
| US-10239828-B2 | Process for preparing guanidino-functional monomers | GMPS, GUCY1B2, GUCY1A1 | MEN1 2441/4885KMT2A 2418/4885CYP1A2 815/4885 |
| US-20170183299-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | GMPS, GUCY1B2, GUCY1A1 | MEN1 2441/4885KMT2A 2418/4885CYP1A2 815/4885 |
| US-20010038824-A1 | Intranasal cyclic peptide formulations | VIP, NPPA, SSTR5 | MEN1 170/4885KMT2A 4834/4885CYP1A2 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.